Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities

Clinical Nuclear Medicine
Lidija AntunovicVincenzo Canzonieri


This study aimed to evaluate the efficiency of 18F-FDG PET/CT in suspected recurrence of epithelial ovarian cancer, after treatment, comparing outcomes of PET/CT with histological tumor subtype, CA-125 serum levels, and findings of conventional diagnostic imaging modalities (CI). Data from 121 women who underwent FDG PET/CT for suspected recurrence of epithelial ovarian cancer after treatment were reviewed retrospectively. Of all patients, 80% had recurrent disease and 20% were disease-free on the final clinical diagnosis. PET/CT showed true-positive findings in 82% of patients, whereas CI demonstrated true-positives in 70% of cases. At the time of PET/CT scanning, only 55 patients had serum CA-125 level greater than 35 U/mL, whereas 52 patients presented with CA-125 levels in a reference range. PET/CT sensitivity (82%) was significantly higher than that of CA-125 (59%), whereas difference in sensitivity between PET/CT and CI (69%) was limited. PET/CT specificity (87%) was significantly better than that of CI (47%), although no difference in specificity between PET/CT and CA-125 (80%) was found. However, no difference in CA-125 serum levels between patients with local tumor relapse and those with distant metastases was found. P...Continue Reading


Apr 5, 2000·AJR. American Journal of Roentgenology·K L BergerB A Siegel
Feb 24, 2001·CA: a Cancer Journal for Clinicians·E E Partridge, M N Barnes
May 25, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Tatsuo TorizukaYasuomi Ouchi
May 14, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Richard von GeorgiKarsten Münstedt
Aug 5, 2004·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Christian MenzelFrank Grünwald
Mar 26, 2005·Gynecologic Oncology·Laura J HavrileskyEvan R Myers
May 17, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C NanniS Fanti
Jul 2, 2005·International Journal of Clinical Oncology·Munetaka TakekumaTatsuo Torizuka
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y NakamotoS Fujii
Dec 21, 2006·European Journal of Nuclear Medicine and Molecular Imaging·G MangiliF Fazio
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A GadducciE Sartori
Feb 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·María José García-VellosoJosé Angel Richter
Nov 7, 2008·Nuclear Medicine Communications·Andrei H IagaruSanjiv Sam Gambhir
Sep 10, 2009·Journal of the National Cancer Institute·Radha Chitale
Feb 16, 2010·The American Journal of Surgical Pathology·Robert J Kurman, Ie-Ming Shih
Mar 12, 2010·Archives of Gynecology and Obstetrics·Hun-Shan PanYen-Kung Chen
Aug 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Priya BhosaleRevathy B Iyer
Jan 18, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Azahara PalomarStefano Fanti
Sep 6, 2011·Clinical Nuclear Medicine·Chiara FuccioDomenico Rubello

❮ Previous
Next ❯


Nov 7, 2015·Revista española de medicina nuclear e imagen molecular·M MayoralP Paredes
Jun 17, 2015·Nuklearmedizin. Nuclear Medicine·M FularzM Ruchała
Mar 18, 2016·Future Oncology·Seyed Mohammad AbediSeyed Jalal Hosseinimehr
Mar 19, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Zhao LimeiLiang Zhiqing
Jan 4, 2019·The British Journal of Radiology·Sherif ElsherifPriya Bhosale
May 4, 2013·Clinical Nuclear Medicine·Cécile CaoduroHatem Boulahdour
Feb 10, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Benjapa KhiewvanAbass Alavi
Oct 22, 2019·Seminars in Nuclear Medicine·Jukka KemppainenMarko Seppänen
Mar 23, 2021·Revista española de medicina nuclear e imagen molecular·Paloma García-TalaveraFelipe Gómez-Caminero

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.